Michael Milken Wants to Speed Up Cures
By Mark Kreidler
In his new book, “Faster Cures,” the former “junk bond king,” now a philanthropist, promotes business principles as catalysts for medical breakthroughs.
ER Doctors Vow to Pursue Case Against Envision Despite Bankruptcy
By Bernard J. Wolfson
The lawyer for an emergency physicians group says its lawsuit against Envision Healthcare should be allowed to proceed even though the company has filed for Chapter 11 protection.
Daily Edition for Friday, May 12, 2023
Covid, blood donations, mpox, drug prices, opioids, youth mental health, guns, and more are in the day’s news.
‘A System in Crisis’: Dysfunctional Federal Disability Programs Force the Poor to Pass Up Money
By Fred Clasen-Kelly
With little or no income, disability applicants are seeking Social Security early retirement benefits even though it could cost them tens of thousands of dollars in future income, lawyers say.
KFF Health News' 'What the Health?': The Crisis Is Officially Ending, but Covid Confusion Lives On
The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.
Daily Edition for Thursday, May 11, 2023
AI in health care, end of the covid emergency, Title 42, health worker shortages, reproductive health, opioids, and more are in the news.
La inteligencia artificial puede estar llegando a los consultorios, pero no está lista para ver pacientes
By Darius Tahir
Las empresas quieren que sus IA tomen notas para los médicos y ofrezcan una segunda opinión, suponiendo que puedan evitar que divulgue la información privada de los pacientes.
PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention
By Arthur Allen
Drugmakers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Congress is finally on board, too, but will it matter?
AI May Be on Its Way to Your Doctor’s Office, But It’s Not Ready to See Patients
By Darius Tahir
Giant corporations like Microsoft and Google, plus many startups, are eyeing health care profits from programs based on artificial intelligence.
An Arm and a Leg: Mental Health ‘Ghost Networks’ — And a Ghostbuster
By Dan Weissmann
What should you do when your search for an in-network mental health care provider comes up empty? Abigail Burman has some expertise to share.
